The Turning the Tide Against Cancer 2014 National Conference is one month
away! Register now and join key stakeholders in the cancer community on
October 9th in Washington, D.C., to take part in panel discussions and spotlight
series that will explore potential policy solutions that support patient-centered,
high-value cancer research and care, while addressing challenges with rising
healthcare costs.
View the full agenda of scheduled spotlight speakers and panelists.
| Special Guest Speaker: |
| • | Suleika Jaouad, The New York Times Emmy® Award Winning Columnist,
"Life, Interrupted," and Cancer Survivor |
|
Speakers and Panelists Include: |
| • | Amy Abernethy, M.D., Ph.D., Professor of Medicine, Duke University
School of Medicine; Chief Medical Officer and Senior Vice President of
Oncology, Flatiron Health, Inc.
|
| • | Anna Barker, Ph.D., Co-Director, Complex Adaptive Systems Initiative;
President and Director, National Biomarker Development Alliance; Professor,
School of Life Sciences, Arizona State University
|
| • | Tanisha V. Carino, Ph.D., Executive Vice President, Avalere Health
|
| • | John J. Castellani, President and CEO, Pharmaceutical Research and
Manufacturers of America |
| |
•
• | Tony Coelho, Former Member, U.S. House of Representatives;
Chairman, Partnership to Improve Patient Care
Newton F. Crenshaw, Vice President, North American Oncology
Commercial Operations, Global Business Development and Advocacy,
Eli Lilly and Company
|
| • | William S. Dalton, Ph.D., M.D., CEO, M2Gen; Director, DeBartolo Family
Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research
Institute
|
•
• | Stephen L. Eck, M.D., Ph.D., Vice President, Global Head of Oncology
Medical Sciences, Astellas Pharma Global Development
Shelley Fuld Nasso, M.P.P., CEO, National Coalition for Cancer Survivorship
|
| • | Patricia J. Goldsmith, CEO, CancerCare
|
| • | Roy S. Herbst M.D., Ph.D., Ensign Professor of Medicine, Professor
of Pharmacology, Chief of Medical Oncology, Director of the Thoracic
Oncology Research Program, and Associate Director for Translational
Research, Yale Comprehensive Cancer Center and Yale School of
Medicine
|
| • | Linda House, R.N., B.S.N., M.S.M., Executive Vice President,
External Affairs, Cancer Support Community
|
| • | Robert J. Hugin, Chairman and CEO, Celgene Corporation
|
| • | Paul G. Kluetz, M.D., Acting Deputy Office Director, Prostate Cancer
Scientific Liaison, Office of Hematology and Oncology Products,
U.S. Food and Drug Administration
|
| • | Michael Kolodziej, M.D., National Medical Director, Oncology Solutions,
Office of the Chief Medical Officer, Aetna
|
| • | Jennifer Malin, M.D., Ph.D., Medical Director for Oncology for Care
Management, WellPoint, Inc. |
| |
| • | Lee N. Newcomer, M.D., M.H.A., Senior Vice President, Oncology,
Genetics and Women's Health, UnitedHealthcare
|
| • | Richard L. Schilsky, M.D., FASCO, Chief Medical Officer, American
Society of Clinical Oncology; Professor Emeritus, University of Chicago
|
| • | Lowell Schnipper, M.D., Theodore W. and Evelyn G. Berenson Professor,
Department of Medicine, Harvard Medical School; Chief, Hematology/Oncology,
Beth Israel Deaconess Medical Center; Clinical Director, Beth Israel
Deaconess Medical Center Cancer Center
|
| • | Jeff A. Walker, M.B.A., Senior Executive Director for Administration,
Comprehensive Cancer Center and James Cancer Hospital/Solove
Research Institute, The Ohio State University
 |
|
 | |
| Date: | Thursday, October 9, 2014 |
| Time: | 8:30 a.m. to 4:00 p.m. |
| Location: | The Knight Conference Center at the Newseum, Washington, D.C. |
| Website: | TurningTheTideAgainstCancer.org
#TurnTheTide
|
|
|
.png)
No hay comentarios:
Publicar un comentario